Suppr超能文献

术前硬膜外注射对腰椎融合手术术后感染的影响。

The impact of preoperative epidural injections on postoperative infection in lumbar fusion surgery.

作者信息

Singla Anuj, Yang Scott, Werner Brian C, Cancienne Jourdan M, Nourbakhsh Ali, Shimer Adam L, Hassanzadeh Hamid, Shen Francis H

机构信息

Department of Orthopaedic Surgery, University of Virginia Health System, Charlottesville, Virginia; and.

Children's Orthopaedic Center, Children's Hospital Los Angeles, California.

出版信息

J Neurosurg Spine. 2017 May;26(5):645-649. doi: 10.3171/2016.9.SPINE16484. Epub 2017 Mar 14.

Abstract

OBJECTIVE Lumbar epidural steroid injections (LESIs) are performed for both diagnostic and therapeutic purposes for a variety of indications, including low-back pain, the leading cause of disability and expense due to work-related conditions in the US. The steroid agent used in epidural injections is reported to relieve nerve root inflammation, local ischemia, and resultant pain, but the injection may also have an adverse impact on spinal surgery performed thereafter. In particular, the possibility that preoperative epidural injections may increase the risk of surgical site infection after lumbar spinal fusion has been reported but has not been studied in detail. The goal of the present study was to use a large national insurance database to analyze the association of preoperative LESIs with surgical site infection after lumbar spinal fusion. METHODS A nationwide insurance database of patient records was used for this retrospective analysis. Current Procedural Terminology codes were used to query the database for patients who had undergone LESI and 1- or 2-level lumbar posterior spinal fusion procedures. The rate of postoperative infection after 1- or 2-level posterior spinal fusion was analyzed. These study patients were then divided into 3 separate cohorts: 1) lumbar spinal fusion performed within 1 month after LESI, 2) fusion performed between 1 and 3 months after LESI, and 3) fusion performed between 3 and 6 months after LESI. The study patients were compared with a control cohort of patients who underwent lumbar fusion without previous LESI. RESULTS The overall 3-month infection rate after lumbar spinal fusion procedure was 1.6% (1411 of 88,540 patients). The infection risk increased in patients who received LESI within 1 month (OR 2.6, p < 0.0001) or 1-3 months (OR 1.4, p = 0.0002) prior to surgery compared with controls. The infection risk was not significantly different from controls in patients who underwent lumbar fusion more than 3 months after LESI. CONCLUSIONS Lumbar spinal fusion performed within 3 months after LESI may be associated with an increased rate of postoperative infection. This association was not found when lumbar fusion was performed more than 3 months after LESI.

摘要

目的 腰椎硬膜外类固醇注射(LESIs)用于多种适应症的诊断和治疗,包括腰痛,在美国,腰痛是因工作相关疾病导致残疾和费用的主要原因。据报道,硬膜外注射中使用的类固醇药物可缓解神经根炎症、局部缺血及由此产生的疼痛,但该注射也可能对其后进行的脊柱手术产生不利影响。特别是,术前硬膜外注射可能增加腰椎融合术后手术部位感染风险的可能性已被报道,但尚未进行详细研究。本研究的目的是使用一个大型国家保险数据库来分析术前LESIs与腰椎融合术后手术部位感染之间的关联。

方法 本回顾性分析使用了一个全国性的患者记录保险数据库。使用当前程序编码术语在数据库中查询接受过LESIs和1或2节段腰椎后路脊柱融合手术的患者。分析1或2节段后路脊柱融合术后的感染率。然后将这些研究患者分为3个独立队列:1)在LESIs后1个月内进行腰椎融合,2)在LESIs后1至3个月进行融合,3)在LESIs后3至6个月进行融合。将研究患者与未进行过LESIs的腰椎融合对照组患者进行比较。

结果 腰椎融合手术后3个月的总体感染率为1.6%(88540例患者中的1411例)。与对照组相比,术前1个月内(比值比2.6,p<0.0001)或1至3个月内(比值比1.4,p = 0.0002)接受LESIs的患者感染风险增加。在LESIs后3个月以上进行腰椎融合的患者中,感染风险与对照组无显著差异。

结论 在LESIs后3个月内进行腰椎融合可能与术后感染率增加有关。当在LESIs后3个月以上进行腰椎融合时,未发现这种关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验